PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.73%
Revenue growth under 50% of MTDR's 32.15%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
14.09%
Gross profit growth under 50% of MTDR's 50.19%. Michael Burry would be concerned about a severe competitive disadvantage.
104.96%
EBIT growth above 1.5x MTDR's 58.63%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
104.96%
Operating income growth above 1.5x MTDR's 58.63%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
64.88%
Net income growth at 50-75% of MTDR's 92.27%. Martin Whitman would question fundamental disadvantages in expenses or demand.
64.56%
EPS growth at 50-75% of MTDR's 91.21%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
64.56%
Diluted EPS growth at 50-75% of MTDR's 92.13%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.91%
Share reduction while MTDR is at 0.18%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
49.35%
Maintaining or increasing dividends while MTDR cut them. John Neff might see a strong edge in shareholder returns.
8.27%
OCF growth at 50-75% of MTDR's 12.79%. Martin Whitman would question if the firm lags in monetizing sales effectively.
21.80%
FCF growth 50-75% of MTDR's 33.46%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-56.46%
Negative 10Y revenue/share CAGR while MTDR stands at 814.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.99%
5Y revenue/share CAGR under 50% of MTDR's 324.85%. Michael Burry would suspect a significant competitive gap or product weakness.
5.31%
3Y revenue/share CAGR under 50% of MTDR's 126.73%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-65.22%
Negative 10Y OCF/share CAGR while MTDR stands at 613.56%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
191.43%
Below 50% of MTDR's 395.99%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-31.84%
Negative 3Y OCF/share CAGR while MTDR stands at 75.41%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-134.36%
Negative 10Y net income/share CAGR while MTDR is at 1007.43%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-115.16%
Negative 5Y net income/share CAGR while MTDR is 1262.13%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-237.14%
Negative 3Y CAGR while MTDR is 1038.01%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-86.88%
Negative equity/share CAGR over 10 years while MTDR stands at 129.67%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-59.33%
Negative 5Y equity/share growth while MTDR is at 208.55%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-56.57%
Negative 3Y equity/share growth while MTDR is at 8.50%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-85.59%
Cut dividends over 10 years while MTDR stands at 1450.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
90.00%
Dividend/share CAGR of 90.00% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
96.33%
3Y dividend/share CAGR of 96.33% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.08%
AR growth is negative/stable vs. MTDR's 14.96%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
-0.95%
Negative asset growth while MTDR invests at 3.94%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.60%
We have a declining book value while MTDR shows 11.89%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-9.01%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.01%
We cut SG&A while MTDR invests at 0.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.